These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9714142)

  • 1. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.
    Rainwater DL; Haffner SM
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1335-41. PubMed ID: 9714142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
    Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
    Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the genetic elements controlling lipoprotein(a) concentrations in Mexican Americans. Evidence for at least three controlling elements linked to LPA, the locus encoding apolipoprotein(a).
    Rainwater DL; Kammerer CM; VandeBerg JL; Hixson JE
    Atherosclerosis; 1997 Feb; 128(2):223-33. PubMed ID: 9050779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis for multimodal relationship between apolipoprotein (a) size and lipoprotein (a) concentration in Mexican-Americans.
    Rainwater DL
    Atherosclerosis; 1995 Jun; 115(2):165-71. PubMed ID: 7661875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lp(a) concentrations are related to plasma lipid concentrations.
    Rainwater DL
    Atherosclerosis; 1996 Nov; 127(1):13-8. PubMed ID: 9006799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that multiple genes influence baseline concentrations and diet response of Lp(a) in baboons.
    Rainwater DL; Kammerer CM; VandeBerg JL
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2696-700. PubMed ID: 10559013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) is associated with basal insulin levels in patients with type 2 Diabetes Mellitus.
    Habib SS; Aslam M; Shah SF; Naveed AK
    Arq Bras Cardiol; 2009 Jul; 93(1):28-33. PubMed ID: 19838467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein Lp(a): effects of allelic variation at the LPA locus.
    Rainwater DL; Kammerer CM
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):54-61. PubMed ID: 9723166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp(a) concentrations in NIDDM.
    Haffner SM; Morales PA; Stern MP; Gruber MK
    Diabetes; 1992 Oct; 41(10):1267-72. PubMed ID: 1397699
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitivity and Lp(a) concentrations in normoglycemic men.
    Haffner SM; Karhapaa P; Rainwater DL; Mykkanen L; Aldrete G; Laakso M
    Diabetes Care; 1995 Feb; 18(2):193-9. PubMed ID: 7729297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) levels in African-Americans with NIDDM.
    Scheer WD; Boudreau DA; Cook CB
    Diabetes Care; 1996 Oct; 19(10):1129-34. PubMed ID: 8886562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.
    Cenarro A; Puzo J; Ferrando J; Mateo-Gallego R; Bea AM; Calmarza P; Jarauta E; Civeira F
    Metabolism; 2014 Mar; 63(3):365-71. PubMed ID: 24333007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein(A) levels: a comparison between diabetic and non-diabetic patients with acute ischemic stroke.
    Holanda MM; Filizola RG; Costa MJ; Andrade RV; Silva JA
    Arq Neuropsiquiatr; 2004 Jun; 62(2A):233-6. PubMed ID: 15235723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) in homozygous familial hypercholesterolemia.
    Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.
    Labudovic DD; Toseska KN; Alabakovska SB; B Todorova B
    Clin Biochem; 2003 Oct; 36(7):545-51. PubMed ID: 14563448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.